Immunogenicity 14996
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CTNNA2
Transcript ID
uc010ysj.2
HLA INFO
B*27:02
TCR INFO
No TCR info found!
Full length protein sequence (234 aa)
MAQLP
1
QEEKA
6
KIAEQ
11
VEIFH
16
QEKSK
21
LDAEV
26
AKWDD
31
SGNDI
36
IVLAK
41
QMCMI
46
MMEMT
51
DFTRG
56
KGPLK
61
NTSDV
66
INAAK
71
KIAEA
76
GSRMD
81
KLARA
86
VADQC
91
PDSAC
96
KQDLL
101
AYLQR
106
IALYC
111
HQLNI
116
CSKVK
121
AEVQN
126
LGGEL
131
IVSGL
136
DSATS
141
LIQAA
146
KNLMN
151
AVVLT
156
VKASY
161
VASTK
166
YQKVY
171
GTAAV
176
NSPVV
181
SWKMK
186
APEKK
191
PLVKR
196
EKPEE
201
FQTRV
206
RRGSQ
211
KKHIS
216
PVQAL
221
SEFKA
226
MDSF
231
Mutation Information
DNA mutation:
None
Peptide Range:
208 ~ 232
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"TRVRRGSQKKHISPVQALSEFKAMD
||||||||||||.||||||||||||
Mutant:
TRVRRGSQKKHILPVQALSEFKAMD"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CTNNA2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay